Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 5/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.41 |
| ▸ | CCL5 | P13501 | 14/20 | 0.40 |
| ▸ | CCR5 | P51681 | 8/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4696688 | 0.92 | CCL5 (0.40) | CCL5CCR5 | |
| SCHEMBL4698176 | 0.91 | CCR5 (0.40) | HCRTR1HCRTR2CCL5CCR5 | |
| SCHEMBL4968893 | 0.87 | CCR5 (0.39) | CCL5CCR5 | |
| SCHEMBL4691440 | 0.87 | CCR5 (0.41) | CCL5CCR5 | |
| SCHEMBL4695015 | 0.85 | CCR5 (0.40) | CCL5CCR5 | |
| SCHEMBL4694907 | 0.85 | CCL5 (0.43) | CCL5CCR5 | |
| SCHEMBL4694360 | 0.84 | CCL5 (0.39) | CCL5CCR5 | |
| SCHEMBL3282165 | 0.84 | CCL5 (0.51) | CCL5CCR5 | |
| SCHEMBL3290289 | 0.84 | CCL5 (0.51) | CCL5CCR5 | |
| SCHEMBL4697093 | 0.83 | CCL5 (0.44) | CCL5CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1761542-B1 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | claimed |
| EP-1761542-B1 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | disclosed |
| EP-1871762-A2 | SUBTITUTED HETEROARYL CB1 ANTAGONISTS | NEUROGEN CORPORATION (US) | 2008-01-02 | — | — | EP | disclosed |
| WO-2006113704-A2 | SUBTITUTED HETEROARYL CB1 ANTAGONISTS | NEUROGEN CORPORATION (US) | 2006-10-26 | — | — | WO | disclosed |